Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 New Entrants companies in Imipenem
by Most Patent Filing In 5 Years in the world in 2021

The Imipenem top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filing In 5 Years Imipenem New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Imipenem (Primaxin among others) is an intravenous β-lactam antibiotic discovered by Merck scientists Burton Christensen, William Leanza, and Kenneth Wildonger in the mid-1970s. Carbapenems are highly resistant to the β-lactamase enzymes produced by many multiple drug-resistant Gram-negative bacteria, thus play a key role in the treatment of infections not readily treated with other antibiotics.
#
Company Name
Region
Tech Topics
Total
1
Patent: 10
2
Cataluña, Spain
Public university,Catalan,Kinase,
...[+2]
Patent: 6
3
Cataluña, Spain
Health care
Patent: 5
4
Cataluña, Spain
Patent: 5
5
Nordrhein-Westfalen, Germany
Relative term,Technology transfer,Interventional neuroradiology,
...[+2]
Patent: 3
6
Berlin, Germany
Social science,Biology,Chemistry,
...[+2]
Patent: 3
7
Germany
Patent: 3
8
Schleswig-Holstein, Germany
Patent: 3
9
Patent: 2
10
Patent: 2
11
Patent: 2
12
Patent: 2
13
Patent: 2
14
Patent: 1
15
ZH, CN
Gabapentin,Cardiovascular agent,Drug,
...[+1]
Patent: 1
16
Patent: 1
17
Patent: 1
18
Sepsia Therapeutics SL
Cataluña, Spain
Patent: 1
19
Quebec, Canada
Patent: 1
20
California, United States
Patent: 1
Page generation time: Apr 28 2025